Exercise Effects in Multiple Sclerosis
Launched by UNIVERSITY OF REGINA · Aug 8, 2022
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is exploring how different types of exercise can impact people living with multiple sclerosis (MS). Researchers want to understand how regular exercise might help manage symptoms, improve physical function, and affect the brain and nervous system in individuals with various forms of MS, including progressive and relapsing types. This study will be the first to compare the effects of different exercise routines on the central nervous system for those with MS.
To participate, individuals must be diagnosed with progressive MS by a neurologist and receive a doctor's approval to exercise. They should have a moderate level of motor disability, which is measured by a specific scoring system. Participants should be aged between 65 and 74 and need to meet certain criteria related to their physical activity levels. If you join the study, you'll engage in different exercise programs and help researchers learn how exercise can benefit people with MS. It's an exciting opportunity to contribute to understanding how to improve the quality of life for those living with this condition.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • diagnosis of progressive MS by a neurologist
- • physician clearance for exercise
- • a Patient-Determined Disease Steps (PDSS) score between 3 and 7 (i.e., moderate motor disability)
- • a Timed 25-Foot Walk (T25-FW) test time \> 6.0 s.
- Exclusion Criteria:
- • a baseline score \>24 on the Godin-Shephard Leisure Time Physical Activity Questionnaire (i.e., high physical activity levels)
- • absolute contraindications to TMS (e.g. history of seizure)
- • a history of any neurological conditions other than MS
- • relapse in the past three months (self-reported, neurologist confirmed)
- • psychiatric diagnosis
- • substance abuse
About University Of Regina
The University of Regina, a prominent Canadian institution known for its commitment to academic excellence and research innovation, serves as a clinical trial sponsor dedicated to advancing healthcare through rigorous scientific inquiry. With a focus on interdisciplinary collaboration, the university leverages its diverse expertise to conduct clinical trials that address pressing health challenges and contribute to evidence-based practices. By fostering partnerships with healthcare professionals and community stakeholders, the University of Regina aims to enhance patient outcomes and promote public health through cutting-edge research and ethical trial management.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Regina, Saskatchewan, Canada
Patients applied
Trial Officials
Cameron Mang, PhD
Principal Investigator
University of Regina
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials